NEFL and neurodegenerative disease: The degeneration of neurons is believed to lead to an increase in the levels of NFL in patient biofluids, making it a useful biomarker for neurodegenerative diseases (Gaiottino et al., 2013; Zeitlberger et al., 2018; Siller et al., 2019; Weishaupl et al., 2019).